https://orcid.org/0000-0003-1561-581X
References
- Kelemen K, Peterson LC, Helenowski I, et al. CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease. Am J Clin Pathol. 2008;130(2):166–177.
- Palumbo GA, Parrinello N, Fargione G, et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res. 2009;33(9):1212–1216.
- Sandes AF, de Lourdes Chauffaille M, Oliveira CR, et al. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom. 2013;86(2):98–105.
- Lesesve JF, Tardy S, Frotscher B, et al. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms. Int Jnl Lab Hem. 2015;37(4):486–494.
- Challagundla P, Medeiros LJ, Kanagal-Shamanna R, et al. Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging. Am J Clin Pathol. 2014;142(6):837–844.
- Alapat D, Coviello-Malle J, Owens R, et al. Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma. Am J Clin Pathol. 2012;137(1):93–100.
- Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8(10):1640–1645.
- D’Arena G, Vitale D, Rossi G, et al. CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia. Haematol Oncol. 2018;36:543–546.
- Kohnke T, Wittmann VK, Bucklein VL, et al. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200. Br J Haematol. 2017;179(3):480–487.
- Mora A, Bosch R, Cuellar C, et al. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2019;96(2):143–148.
- Demir C, Kara E, Ekinci O, et al. Clinical and laboratory features of CD5-negative chronic lymphocytic leukemia. Med Sci Monit. 2017;23:2137–2142.
- Soleimani A, Tanios G, Safah H, et al. A systematic review of CD5-negative mantle cell lymphoma identifies potential clinical and biological implications. Blood. 2016;128(22):3048.
- Rawstron AC, Kreuzer KA, Soosapilla A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) harmonisation project. Cytometry B Clin Cytom. 2018;94(1):121–128.
- Dorfman DM, Shahsafaei A. CD200 (OX-2 membrane glycoprotein) expression n b cell-derived neoplasms. Am J Clin Pathol. 2010;134(5):726–733.
- Fan L, Miao Y, Wu YJ, et al. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis. Leuk Lymphoma. 2015;56(12):3329–3335.
- Dasgupta A, Ramani M, Mehrotra V, et al. CD200 expression in B-chronic lymphocytic leukemia-it is not an all or none phenomenon. Cytometry B Clin Cytom. 2013;84(6):406.